Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85551-85600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06599372
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NA
Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Nov 30, 2027
3 conditions
1 sponsor
1 location
NCT04965636
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
PHASE3
Active, not recruiting
16 participants
Started: Jul 11, 2022 · Completed: Oct 9, 2025
1 condition
1 sponsor
14 locations
NCT05288777
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
PHASE2/PHASE3
Recruiting
45 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2029
4 conditions
1 sponsor
1 location
NCT05329103
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
65 participants
Started: Jul 11, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
7 locations
NCT05075317
Time Restricted Eating and Cardiac Rehabilitation
NA
Recruiting
60 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05100888
Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms
NA
Enrolling by invitation
90 participants
Started: Jul 11, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT05232136
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05460273
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
PHASE1/PHASE2
Active, not recruiting
119 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
21 locations
NCT04915248
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
PHASE2
Recruiting
28 participants
Started: Jul 11, 2022 · Completed: Jan 1, 2026
1 condition
2 sponsors
18 locations
NCT05142241
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
PHASE2
Active, not recruiting
14 participants
Started: Jul 11, 2022 · Completed: Sep 29, 2026
4 conditions
1 sponsor
2 locations
NCT05420454
A Study for the Neoadjuvant Treatment of Breast Cancer
PHASE4
Recruiting
1,576 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition
1 sponsor
1 location
NCT04685577
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
PHASE2
Recruiting
60 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05420467
A Study for the Adjuvant Treatment of Breast Cancer
PHASE4
Recruiting
2,413 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition
1 sponsor
1 location
NCT05461664
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
N/A
Recruiting
74 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions
22 sponsors
1 location
NCT04848636
Cardiac Tissue Sodium Assessment in CKD Patients Using Sodium MRI
N/A
Recruiting
150 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05447169
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
N/A
Recruiting
11,625 participants
Started: Jul 10, 2022 · Completed: Jul 1, 2030
1 condition
9 sponsors
1 location
NCT05408728
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
N/A
Enrolling by invitation
52 participants
Started: Jul 10, 2022 · Completed: Aug 31, 2026
3 conditions
1 sponsor
1 location
NCT05722535
Using Shared Decision Making to Improve Family Media Use Planning
NA
Recruiting
300 participants
Started: Jul 10, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT07064746
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
N/A
Recruiting
150 participants
Started: Jul 10, 2022 · Completed: Jul 10, 2027
1 condition
2 sponsors
1 location
NCT05214859
Enhancing Mother-Child Ties and Psychosocial Wellness Through Arts Among Children With Intellectual Disability and Their Mothers
NA
Recruiting
154 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05485077
A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
N/A
Recruiting
18,000 participants
Started: Jul 9, 2022 · Completed: Jul 9, 2028
1 condition
2 sponsors
1 location
NCT05464875
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
N/A
Recruiting
74 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
3 conditions
22 sponsors
1 location
NCT05433350
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
PHASE2/PHASE3
Active, not recruiting
35 participants
Started: Jul 9, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
6 locations
NCT05614765
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
N/A
Active, not recruiting
18,000 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05364606
Patient Specific Talus Spacer Post Approval Study
N/A
Recruiting
50 participants
Started: Jul 8, 2022 · Completed: Nov 30, 2029
1 condition
1 sponsor
6 locations
NCT05463133
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
PHASE1/PHASE2
Recruiting
50 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT04763109
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
NA
Recruiting
15 participants
Started: Jul 8, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05725967
Endoscopic Metabolic and Bariatric Therapies
N/A
Enrolling by invitation
5,000 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2026
16 conditions
1 sponsor
1 location
NCT05839106
Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
200 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT06321640
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
N/A
Recruiting
265 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
8 conditions
1 sponsor
1 location
NCT05262907
Ventripoint Single Ventricle Study
NA
Recruiting
100 participants
Started: Jul 8, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT05616884
Cemented vs. Cementless Unicompartmental Knee Arthroplasty
NA
Enrolling by invitation
100 participants
Started: Jul 8, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05113537
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2027
7 conditions
3 sponsors
1 location
NCT05360446
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
PHASE3
Active, not recruiting
610 participants
Started: Jul 8, 2022 · Completed: Oct 26, 2026
1 condition
1 sponsor
89 locations
NCT05469607
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
NA
Recruiting
13 participants
Started: Jul 8, 2022 · Completed: Jul 31, 2028
1 condition
5 sponsors
1 location
NCT06946264
Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features
PHASE3
Recruiting
400 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05973656
Role of Acetaldehyde in the Development of Oral Cancer
NA
Recruiting
170 participants
Started: Jul 8, 2022 · Completed: Sep 30, 2027
3 conditions
2 sponsors
1 location
NCT05549921
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
PHASE2
Recruiting
70 participants
Started: Jul 8, 2022 · Completed: Sep 1, 2024
1 condition
2 sponsors
2 locations
NCT06653270
Virtual Reality Birth Simulator
NA
Recruiting
300 participants
Started: Jul 8, 2022 · Completed: Jul 30, 2025
4 conditions
1 sponsor
1 location
NCT06087679
The SongDanceT1 Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment.
NA
Active, not recruiting
120 participants
Started: Jul 8, 2022 · Completed: Feb 1, 2024
2 conditions
2 sponsors
1 location
NCT05338970
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
PHASE3
Active, not recruiting
586 participants
Started: Jul 8, 2022 · Completed: Jun 30, 2026
3 conditions
2 sponsors
182 locations
NCT06223932
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
N/A
Active, not recruiting
2,600 participants
Started: Jul 7, 2022 · Completed: Feb 29, 2024
2 conditions
2 sponsors
8 locations
NCT05426681
Spinal Cord Injury Neuroprotection With Glyburide
PHASE1
Recruiting
12 participants
Started: Jul 7, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT05250466
A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
NA
Recruiting
120 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05464823
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
NA
Active, not recruiting
111 participants
Started: Jul 7, 2022 · Completed: May 12, 2027
1 condition
1 sponsor
1 location
NCT05463536
Improvings: Implementing a Protocol to Improve Intrapartum Sonography Skills.
N/A
Recruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05116527
THC Memory & Reward Learning Pilot
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT04674462
Understanding Poor Vaccine Responses to Hepatitis B Vaccination
PHASE4
Recruiting
200 participants
Started: Jul 7, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT05261477
Brain Injury Education and Outpatient Navigation-1stBIEN
NA
Recruiting
300 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
6 locations
NCT04982796
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
PHASE1/PHASE2
Recruiting
30 participants
Started: Jul 7, 2022 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
1709
1710
1711
1712
1713
1714
1715
More pages
2369
Next